Plain-English translation of NCT05030805 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Ovarian Cancer research guide →Researchers are creating a detailed genetic map of ovarian cancer by studying individual cancer cells from tumor samples. This study will examine how different cells within a tumor behave and what makes them unique, which could help doctors understand the disease better and design more targeted treatments in the future.
Ovarian cancer is complex, and different cells within the same tumor can behave very differently. By understanding these differences at a genetic level, researchers hope to identify new ways to fight the disease and potentially predict which treatments will work best for each patient.
You likely qualify if…
You likely don't qualify if…
If you qualify, researchers will collect a small sample of your tumor tissue during or after your surgery at the hospital — this tissue would typically be removed anyway as part of your treatment. The sample will then be sent to the laboratory where scientists will extract individual cells and analyze their genes using specialized equipment. You won't need additional visits or procedures beyond your regular ovarian cancer care.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
France
Enrollment target
~50 participants
Started
May 2022
Primary completion
April 2030
Age range
18 Years – 80 Years
Sex
Female only
Last updated on clinicaltrials.gov in August 2022.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Cherif Akladios, MD
University Hospital, Strasbourg, France
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.